ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $357,000 | -60.7% | 7,900 | -51.2% | 0.00% | -50.0% |
| Q2 2022 | $908,000 | +410.1% | 16,200 | +546.2% | 0.00% | – |
| Q1 2022 | $178,000 | -91.4% | 2,507 | -90.9% | 0.00% | -100.0% |
| Q3 2021 | $2,064,000 | +2168.1% | 27,500 | +1764.4% | 0.00% | – |
| Q2 2020 | $91,000 | -89.9% | 1,475 | -89.5% | 0.00% | -100.0% |
| Q1 2020 | $901,000 | -48.6% | 14,077 | -44.4% | 0.00% | -33.3% |
| Q4 2019 | $1,752,000 | -9.2% | 25,299 | -17.1% | 0.00% | -25.0% |
| Q3 2019 | $1,930,000 | -74.2% | 30,502 | -74.2% | 0.00% | -73.3% |
| Q2 2019 | $7,485,000 | -63.1% | 118,136 | -66.0% | 0.02% | -61.5% |
| Q1 2019 | $20,273,000 | -24.5% | 347,146 | -20.3% | 0.04% | -35.0% |
| Q4 2018 | $26,868,000 | -9.2% | 435,500 | +14.7% | 0.06% | +9.1% |
| Q3 2018 | $29,605,000 | +62.1% | 379,800 | +40.8% | 0.06% | +57.1% |
| Q2 2018 | $18,264,000 | +36.9% | 269,700 | +15.6% | 0.04% | +59.1% |
| Q1 2018 | $13,338,000 | – | 233,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |